Clinical Trials Arena on MSN

ReCode initiates Phase II trial of RCT2100 with ivacaftor for CF

The open-label, multi-part Phase II trial will assess RCT2100’s biodistribution, safety, and tolerability via oral inhalation ...
mobilematters.gg on MSN

Ark Re:Code Codes (November 2025)

Code is an apocalyptic strategy game with an adult theme where you can pull for different characters, form team comps, build ...
Business Wire

ReCode Therapeutics Doses First Patient in Phase 1 Clinical Study of Novel mRNA-based Therapy for the Treatment of Primary Ciliary Dyskinesia

MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, ...
Business Wire

ReCode Therapeutics Announces Appointment of Dean J. Mitchell as Chairman of Its Board of Directors

MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, ...